Besivance approved for bacterial conjunctivitis - MPR
Links shared publicly online about this topic.
- 2,008total visits
Besivance approved for bacterial conjunctivitis - MPR
empr.com —
View full resource at empr.com
Tags: Eye, Eye Infection, Conjunctivitis, FDA, Bausch & Lomb, News
Most Recently Shared on May 29, 2009 at 4:11 pm By:
MPR News: Besivance approved for bacterial conjunctivitis: The FDA approved Besivance (besifloxacin 0.6.. http://tinyurl.com/ko2yy4
Hi-Tech Pharmacal Receives Final Approval For Levofloxacin Ophthalmic Solution - QualityPoint Technologies
qualitypointtech.net — “Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin® ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data. The product is indicated for bacterial conjunctivitis. The Company is preparing ” View full resource at qualitypointtech.net
Most Recently Shared on February 13, 2011 at 11:35 am By:
Hi-Tech Pharmacal Receives Final Approval For Levofloxacin Ophthalmic Solution: Hi-Tech Pharmacal Co., Inc. (NASDA... http://bit.ly/edWqEF
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - ONA
oncologynurseadvisor.com — “The FDA has approved Allergan--™s Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 20, 2010 at 3:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Zymaxid ophthalmic solution approved for bacterial conjunctivitis http://goo.gl/fb/sDmLT
FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis
news-medical.net — “Allergan, Inc. today announced that the United States Food and Drug Administration has approved ZYMAXID (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms; Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumonia.” View full resource at news-medical.net
Most Recently Shared on May 20, 2010 at 8:27 am By:
Obesity News: FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis: Allergan, Inc.... http://twurl.nl/fcuc3y
Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution
drugs.com — “Zymaxid (gatifloxacin ophthalmic solution) is used to treat bacterial conjunctivitis. Includes Zymaxid side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 19, 2010 at 11:38 pm By:
Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution - http://bit.ly/dndI0j
Besifloxacin Approved for Treatment of Conjunctivitis
eyedocnews.com — “MedPage Today reported last week that the FDA had approved besifloxacin ophthalmic suspension 0.6% (Besivance) for the treatment of bacterial conjunctivitis.” View full resource at eyedocnews.com
Most Recently Shared on June 1, 2009 at 5:17 am By:
Dr. Ari Weitzner Physician, Doctor, and Ophthalmologist
Discuss: FDA Approves Besifloxacin Drops for Treatment of Bacterial Conjunctivitis: MedPage Today report.. http://tinyurl.com/njagxg
FDA Approves Bacterial Conjunctivitis Drug Besivance
webmd.com — “The FDA has approved a new antibacterial eyedrop called Besivance to treat bacterial conjunctivitis, which is commonly called” View full resource at webmd.com
Most Recently Shared on May 29, 2009 at 6:25 pm By:
FDA Approves Bacterial Conjunctivitis Drug Besivance: The FDA has approved a new antibacterial eyedrop called Be.. http://tinyurl.com/n2fayy
FDA approves besifloxacin drop for bacterial conjunctivitis
osnsupersite.com — “MADISON, N.J. — The U.S. Food and Drug Administration has approved Bausch & Lomb's besifloxacin ophthalmic suspension 0.6%, a topical antibac” View full resource at osnsupersite.com
Most Recently Shared on May 29, 2009 at 3:22 pm By:
FDA approves besifloxacin drop for bacterial conjunctivitis: http://ow.ly/9SUE
Advertisement
